Insider Trading April 15, 2026 06:58 PM

Photronics Director Sells $225,000 in Stock After Exercising Options; Company Posts Quarterly Beat and Advances Mask Capability

Director Lee Kang Jyh sold 5,000 shares and exercised 5,000 options amid a rally that has the stock near its 52-week high

By Ajmal Hussain PLAB
Photronics Director Sells $225,000 in Stock After Exercising Options; Company Posts Quarterly Beat and Advances Mask Capability
PLAB

Photronics Inc. director Lee Kang Jyh sold 5,000 shares of common stock on April 13, 2026, at $45 per share for $225,000 and simultaneously exercised 5,000 options with an $8.6 strike, costing $43,000. The trade comes as PLAB trades close to a 52-week high following strong one-year returns. Photronics also posted fiscal Q1 2026 results that beat analyst forecasts and disclosed the planned installation of an advanced mask writer at its Korea facility, while Craig-Hallum raised its price target to $48 and maintained a Buy rating.

Key Points

  • Director Lee Kang Jyh sold 5,000 Photronics shares at $45 each on April 13, 2026, and exercised 5,000 options at an $8.6 strike the same day.
  • Photronics reported fiscal Q1 2026 EPS of $0.61 and revenue of $225.07 million, both ahead of analyst projections.
  • The company announced the planned installation of an advanced mask writer at its Korea facility for fiscal Q2 2026 and received a price-target increase to $48 from Craig-Hallum, which maintained a Buy rating.

Transaction details

On April 13, 2026, director Lee Kang Jyh of Photronics Inc. (NASDAQ: PLAB) sold 5,000 shares of the company's common stock at $45 per share, generating proceeds of $225,000. On the same day, Lee exercised options to acquire 5,000 shares at an exercise price of $8.6, for a total outlay of $43,000.

Ownership following the transactions

After completing the sale and the option exercise, Lee directly holds 385,850 shares of Photronics common stock. The exercised options were part of a grant with a stated vesting schedule and an expiration date that remains relevant for future exercises.

Options terms

The options Lee exercised have an $8.6 exercise price. According to the documented vesting schedule, these options vested in four equal annual installments, with 25% vesting on each of the first four anniversaries of the grant date, which was January 2, 2018. The options are exercisable for Photronics common stock and carry an expiration date of January 2, 2028.

Market context

Photronics shares have climbed sharply over the last year, producing a 155% total return. As of the reporting around these transactions, the stock was trading close to its 52-week high of $46.49. Separately, InvestingPro analysis cited in the reporting indicates the stock currently appears overvalued relative to its Fair Value.

Recent financial performance and operational developments

Photronics reported fiscal first-quarter 2026 results that surpassed analyst expectations. The company delivered earnings per share of $0.61, versus the projected $0.5267, a positive surprise of 15.82%. Revenue for the quarter reached $225.07 million, topping the forecast of $220.83 million by 1.92%.

Operationally, Photronics announced plans to install an advanced mask writer at its Korea facility. The company indicated that the installation is scheduled for fiscal Q2 2026 and is expected to enhance production capabilities for AMOLED photomasks. The announcement was described as a technological step for the company in the area of photomask manufacturing.

Analyst action and governance

Craig-Hallum raised its price target on Photronics to $48, up from $42, while maintaining a Buy rating. The firm attributed the higher target to Photronics’ strategic position as semiconductor manufacturers increasingly outsource photomask production.

At the company’s annual shareholders’ meeting, eight directors were elected to Photronics’ board, and shareholders approved the company’s auditor and executive compensation. These governance actions were recorded alongside the operational and financial updates.

What the record shows

The filings and company statements set out the sale, the option exercise, the vesting and expiration schedule of the options, the company’s recent earnings beat, the planned mask writer installation in Korea, the analyst price-target increase, and the annual meeting outcomes. The public information does not attribute a reason for Lee’s sale beyond the recorded transaction data.


Note: This report presents the transaction and corporate developments as disclosed in filings and company announcements.

Risks

  • Valuation risk: InvestingPro analysis indicates the stock appears overvalued relative to its Fair Value, which may affect investor expectations in the semiconductor and equipment markets.
  • Timing risk for option activity: The exercised options expire on January 2, 2028, establishing a finite window for any remaining option exercises.
  • Market sensitivity: PLAB is trading near its 52-week high after a 155% one-year gain, a price level that can be associated with higher volatility in semiconductor-related equities.

More from Insider Trading

Infinite Acquisitions Sells 3.95M Falcon’s Beyond Shares in $52.83M Transaction Apr 15, 2026 Remitly CLCAO Somalya Saema Disposes $650K of RELY Shares in Two Scheduled Trades Apr 15, 2026 Remitly Director Joshua Hug Disposes $434,695 in Stock via 10b5-1 Plan Apr 15, 2026 Charles Schwab Executive Sells $2.15M in Stock After Exercising Options Apr 15, 2026 Slide Insurance Risk Chief Sells $180,000 in Stock; Exercises 10,000 Options Apr 15, 2026